Spectral Medical, Inc. (EDT.TO)
1.00
-0.08
(-7.41%)
CAD |
TSX |
Oct 23, 16:00
Spectral Medical Net Income (Quarterly) : 0.331M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.331M |
| March 31, 2026 | -2.935M |
| December 31, 2025 | -2.837M |
| September 30, 2025 | -30.32M |
| June 30, 2025 | -1.933M |
| March 31, 2025 | -12.60M |
| December 31, 2024 | 3.158M |
| September 30, 2024 | -9.995M |
| June 30, 2024 | -4.402M |
| March 31, 2024 | -4.157M |
| December 31, 2023 | -6.525M |
| September 30, 2023 | -3.675M |
| June 30, 2023 | -4.288M |
| March 31, 2023 | -1.095M |
| December 31, 2022 | -1.19M |
| September 30, 2022 | -2.343M |
| June 30, 2022 | -2.055M |
| March 31, 2022 | -2.036M |
| December 31, 2021 | -2.552M |
| September 30, 2021 | -2.067M |
| June 30, 2021 | -2.521M |
| March 31, 2021 | -1.645M |
| December 31, 2020 | -2.147M |
| September 30, 2020 | -1.577M |
| June 30, 2020 | -1.949M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.425M |
| December 31, 2019 | -1.414M |
| September 30, 2019 | -1.401M |
| June 30, 2019 | -1.052M |
| March 31, 2019 | -0.993M |
| December 31, 2018 | 0.444M |
| September 30, 2018 | -0.709M |
| June 30, 2018 | -1.51M |
| March 31, 2018 | -0.714M |
| December 31, 2017 | -1.076M |
| September 30, 2017 | -0.857M |
| June 30, 2017 | -1.15M |
| March 31, 2017 | -0.993M |
| December 31, 2016 | -1.024M |
| September 30, 2016 | -2.633M |
| June 30, 2016 | -3.498M |
| March 31, 2016 | -2.994M |
| December 31, 2015 | -2.40M |
| September 30, 2015 | -2.493M |
| June 30, 2015 | -2.366M |
| March 31, 2015 | -2.265M |
| December 31, 2014 | -1.854M |
| September 30, 2014 | -2.012M |
| June 30, 2014 | -2.451M |
| March 31, 2014 | -3.175M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Resverlogix Corp. | -8.421M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | -0.2796M |
| Restart Life Sciences Corp. | -1.017M |
| Defence Therapeutics Inc | -2.962M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.621M |
| Total Expenses (Quarterly) | 0.29M |
| EPS Diluted (Quarterly) | 0.0011 |
| Enterprise Value | 317.48M |
| Gross Profit Margin (Quarterly) | -186.3% |
| Profit Margin (Quarterly) | 53.30% |
| Earnings Yield | -12.42% |
| Normalized Earnings Yield | -7.77 |